Jacobi Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $601K | Hold |
4,706
| – | – | 0.03% | 376 |
|
|
2025
Q4 | $574K | Buy |
4,706
+15
| +0.3% | +$1.72K | 0.03% | 378 |
|
|
2025
Q3 | $470K | Sell |
4,691
-28
| -0.6% | -$2.52K | 0.03% | 409 |
|
|
2025
Q2 | $391K | Sell |
4,719
-147
| -3% | -$11.7K | 0.03% | 444 |
|
|
2025
Q1 | $395K | Sell |
4,866
-114
| -2% | -$10.2K | 0.03% | 420 |
|
|
2024
Q4 | $449K | Sell |
4,980
-93
| -2% | -$9.01K | 0.03% | 373 |
|
|
2024
Q3 | $501K | Sell |
5,073
-257
| -5% | -$25.3K | 0.04% | 347 |
|
|
2024
Q2 | $494K | Sell |
5,330
-57
| -1% | -$5.11K | 0.04% | 317 |
|
|
2024
Q1 | $511K | Hold |
5,387
| – | – | 0.05% | 305 |
|
|
2023
Q4 | $481K | Sell |
5,387
-22
| -0.4% | -$1.63K | 0.05% | 298 |
|
|
2023
Q3 | $395K | Buy |
5,409
+32
| +0.6% | +$2.56K | 0.04% | 308 |
|
|
2023
Q2 | $447K | Sell |
5,377
-238
| -4% | -$19.9K | 0.05% | 292 |
|
|
2023
Q1 | $428K | Buy |
5,615
+365
| +7% | +$30.3K | 0.05% | 292 |
|
|
2022
Q4 | $436K | Sell |
5,250
-15
| -0.3% | -$1.21K | 0.05% | 286 |
|
|
2022
Q3 | $418K | Sell |
5,265
-95
| -2% | -$8.01K | 0.06% | 278 |
|
|
2022
Q2 | $398K | Buy |
5,360
+745
| +16% | +$55.9K | 0.05% | 290 |
|
|
2022
Q1 | $415K | Buy |
4,615
+595
| +15% | +$54.9K | 0.05% | 294 |
|
|
2021
Q4 | $450K | Sell |
4,020
-72
| -2% | -$8.68K | 0.05% | 291 |
|
|
2021
Q3 | $514K | Hold |
4,092
| – | – | 0.07% | 242 |
|
|
2021
Q2 | $554K | Hold |
4,092
| – | – | 0.07% | 220 |
|
|
2021
Q1 | $555K | Buy |
4,092
+4
| +0.1% | +$599 | 0.08% | 204 |
|
|
2020
Q4 | $575K | Sell |
4,088
-35
| -0.8% | -$4.48K | 0.09% | 179 |
|
|
2020
Q3 | $459K | Buy |
4,123
+3
| +0.1% | +$336 | 0.08% | 195 |
|
|
2020
Q2 | $461K | Hold |
4,120
| – | – | 0.09% | 186 |
|
|
2020
Q1 | $319K | Buy |
4,120
+592
| +17% | +$52.4K | 0.07% | 207 |
|
|
2019
Q4 | $336K | Hold |
3,528
| – | – | 0.06% | 232 |
|
|
2019
Q3 | $269K | Sell |
3,528
-29
| -0.8% | -$2.41K | 0.05% | 246 |
|
|
2019
Q2 | $312K | Hold |
3,557
| – | – | 0.06% | 233 |
|
|
2019
Q1 | $322K | Sell |
3,557
-49
| -1% | -$4.17K | 0.08% | 173 |
|
|
2018
Q4 | $259K | Sell |
3,606
-614
| -15% | -$49.5K | 0.07% | 186 |
|
|
2018
Q3 | $405K | Sell |
4,220
-37
| -0.9% | -$3.59K | 0.11% | 118 |
|
|
2018
Q2 | $405K | Buy |
4,257
+88
| +2% | +$8.09K | 0.12% | 116 |
|
|
2018
Q1 | $350K | Buy |
4,169
+96
| +2% | +$8.76K | 0.1% | 115 |
|
|
2017
Q4 | $348K | Sell |
4,073
-821
| -17% | -$68.8K | 0.11% | 105 |
|
|
2017
Q3 | $429K | Buy |
4,894
+118
| +2% | +$9.46K | 0.15% | 85 |
|
|
2017
Q2 | $368K | Buy |
4,776
+2,376
| +99% | +$169K | 0.14% | 76 |
|
|
2017
Q1 | $161K | Buy |
+2,400
| New | +$161K | 0.08% | 115 |
|
Other funds holding XBI
Jacobi Capital Management's XBI Position: Q1 2026 in Review
Jacobi Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 4,706 shares worth $601K. The position accounts for 0.03% of the portfolio, ranked #376.
Jacobi Capital Management first reported a position in XBI in Q1 2017 and has held it in 37 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Jacobi Capital Management held 4,706 shares of State Street SPDR S&P Biotech ETF worth $601K as of Q1 2026.
- Jacobi Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.03% of Jacobi Capital Management's portfolio in Q1 2026, its #376 holding.
- Jacobi Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 37 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.